Establishment of In Vitro P-Glycoprotein Inhibition Assay and Its Exclusion Criteria to Assess the Risk Of Drug–Drug Interaction at the Drug Discovery Stage-Reference-Cited by-同舟云学术

Establishment of In Vitro P-Glycoprotein Inhibition Assay and Its Exclusion Criteria to Assess the Risk Of Drug–Drug Interaction at the Drug Discovery Stage

Published:2011-09 Issue:9 Volume:100 Page:4013-4023
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Sugimoto Hiroshi,Matsumoto Shin-Ichi,Tachibana Miho,Niwa Shin-Ichi,Hirabayashi Hideki,Amano Nobuyuki,Moriwaki Toshiya

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference39 articles.

1. Membrane transporters in drug development;Giacomini;Nat Rev Drug Discov,2010

2. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells;Tsuji;Life Sci,1992

3. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview;Schinkel;Adv Drug Deliv Rev,2003

4. P-glycoprotein related drug interactions: Clinical importance and a consideration of disease states;Lee;Expert Opin Drug Metab Toxicol,2010

5. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood–brain barrier in rats;Sugimoto;Drug Metab Dispos,2011

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of P‐gp inhibition on systemic exposure of pralsetinib and dosing considerations;Clinical and Translational Science;2024-05-28

2. Translatability of in vitro Inhibition Potency to in vivo P-Glycoprotein Mediated Drug Interaction Risk;Journal of Pharmaceutical Sciences;2023-06

3. Discovery and characterization of highly potent and selective covalent inhibitors of SARS-CoV-2 PLpro;2023-05-02

4. Neurotoxicity evoked by organophosphates and available countermeasures;Archives of Toxicology;2022-11-06

5. Do differences in cell lines and methods used for calculation of IC₅₀ values influence categorisation of drugs as P-glycoprotein substrates and inhibitors?;Xenobiotica;2022-07-03